Aditxt, Inc. announced on March 13 the acquisition of Ignite Proteomics, LLC, based in Golden, Colorado. Under the terms of the transaction documents, Aditxt acquired Ignite in a transaction providing 36,000 shares of Aditxt’s newly designated Series A-2 Convertible Preferred Stock, representing an aggregate stated value of $36 million. Ignite Proteomics is a commercial-stage precision oncology company focused […]
The post Aditxt Buys Golden, Colorado-Based Ignite Proteomics appeared first on LevinPro Healthcare M&A – The latest healthcare M&A news.
